TrialInvestigative and clinical urology2024

Efficacy and safety evaluation of imidafenacin administered twice daily for continency recovery following radical prostatectomy in prostate cancer patients: Prospective open-label case-controlled randomized trial.

Jun Hee Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.